Stockscreener 앱 받기
8.40
2.31%
0.19
시간 외 거래:
8.01
-0.39
-4.64%
전일 마감가:
$8.21
열려 있는:
$8.4
하루 거래량:
3,048
Relative Volume:
0.41
시가총액:
$1.55B
수익:
$630.00K
순이익/손실:
$5.72M
주가수익비율:
-24.60
EPS:
-0.3415
순현금흐름:
$-6.75M
1주 성능:
-1.18%
1개월 성능:
+10.53%
6개월 성능:
+11.55%
1년 성능:
-4.38%
1일 변동 폭
$8.40
$8.40
1주일 범위
$8.19
$8.48
52주 변동 폭
$6.51
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
ADXN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
8.40 | 9.09M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
ONC
Beigene Ltd Adr
|
241.43 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr 주식(ADXN)의 최신 뉴스
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewswire Inc.
Coincheck Group N.V (CNCK) produces promising results - US Post News
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN
Golden Heaven Group secures investment of $25.2M - MSN
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
LYRA Stock Quote Price and Forecast - CNN
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr (ADXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
17.27%
1.06%
자본화:
|
볼륨(24시간):